Lucid Diagnostics News

Lucid Diagnostics | 10-Q: Q2 2024 Earnings Report

Aug 12 20:35

Lucid Diagnostics | 8-K: Lucid Diagnostics Provides Business Update and Second Quarter 2024 Financial Results

Aug 12 20:20

Lucid Diagnostics | 8-K: Current report

Jul 25 01:33

Lucid Diagnostics | 424B3: Prospectus

Jul 19 21:07

Lucid Diagnostics | EFFECT: Others

Jul 19 18:06

Lucid Diagnostics | CORRESP: CORRESP

Jul 16 01:30

Lucid Diagnostics | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)

Jul 13 04:35

Lucid Diagnostics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ayrton Capital LLC(9.9%),Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B(9.9%), etc.

Jul 9 03:53

Lucid Diagnostics | UPLOAD: Others

Jul 9 01:30

Lucid Diagnostics | S-3: Registration statement for specified transactions by certain issuers

Jul 2 05:30

Lucid Diagnostics | 8-K: Current report

Jun 22 05:17

Lucid Diagnostics | DEF 14A: Definitive information statements

Jun 6 21:51

Lucid Diagnostics | DEFA14A: Others

Jun 6 20:41

Lucid Diagnostics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

May 25 05:28

Lucid Diagnostics | DEFA14A: Others

May 25 04:39

Lucid Diagnostics | 8-K: Current report

May 25 04:35

Lucid Diagnostics | 8-K: Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results

May 14 18:09

Lucid Diagnostics | 10-Q: Q1 2024 Earnings Report

May 13 20:24

Lucid Diagnostics | 4: Statement of changes in beneficial ownership of securities-Director Matheis Dennis

May 10 10:03

Lucid Diagnostics | 3: Initial statement of beneficial ownership of securities-Director Matheis Dennis

May 10 10:03